Page last updated: 2024-09-03

iguratimod and isoxazoles

iguratimod has been researched along with isoxazoles in 2 studies

Compound Research Comparison

Studies
(iguratimod)
Trials
(iguratimod)
Recent Studies (post-2010)
(iguratimod)
Studies
(isoxazoles)
Trials
(isoxazoles)
Recent Studies (post-2010) (isoxazoles)
134191098,6339003,337

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawabata, D; Mimori, T1
Gu, Y; Jin, B; Liu, W; Luo, Q; Qian, C; Shen, Y; Sun, Y; Tao, F; Wu, X; Xu, Q1

Reviews

1 review(s) available for iguratimod and isoxazoles

ArticleYear
[Disease modifying anti-rheumatic drugs (DMARDs): an overview].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 1

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Benzopyrans; Cysteine; Evidence-Based Medicine; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Meta-Analysis as Topic; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Sulfonamides

2005

Other Studies

1 other study(ies) available for iguratimod and isoxazoles

ArticleYear
A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide.
    Journal of immunology (Baltimore, Md. : 1950), 2013, Nov-15, Volume: 191, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Chromones; Collagen; I-kappa B Kinase; Inflammation; Interleukin-17; Isoxazoles; Leflunomide; Male; Methotrexate; Mice; Mice, Inbred DBA; Phosphorylation; Signal Transduction; Sulfonamides; Synovial Membrane; TNF Receptor-Associated Factor 5

2013